Showing results (721-730 of 1,128) with videos related to
Sort By:
Pageof 113
Arthritis and Rheumatism|July 20, 2011
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung diseaseDinesh Khanna, Rajeev Saggar, Maureen D Mayes, et al.The Journal of Rheumatology|February 17, 2007
Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosisVanessa L Malcarne, Ingunn Hansdottir, Ann McKinney, et al.Journal of the American Chemical Society|November 1, 2008
Highly conducting transmembrane pores formed by aromatic oligoamide macrocyclesAmber Jade Helsel, Amy L Brown, Kazuhiro Yamato, et al.Biorxiv : the Preprint Server for Biology|April 22, 2024
Measuring the burden of hundreds of BioBricks defines an evolutionary limit on constructability in synthetic biologyNoor Radde, Genevieve A Mortensen, Diya Bhat, et al.Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|July 9, 1998
The role of pharmacy in the management of patients with temporomandibular disorders and orofacial painG A Brazeau, H A Gremillion, C G Widmer, et al.Cancer|September 15, 1993
A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center StudyT M Kuzel, M S Tallman, D Shevrin, et al.JAMA Network Open|January 22, 2024
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer CohortWade T Iams, Matthew Mackay, Rotem Ben-Shachar, et al.British Journal of Cancer|June 10, 2004
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteS Bamford, E Dawson, S Forbes, et al.Arthritis Research & Therapy|January 18, 2019
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Dinesh Khanna, Philip J Clements, Elizabeth R Volkmann, et al.ACR Open Rheumatology|February 17, 2022
Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent CohortsKristofer Andréasson, S Melanie Lee, Venu Lagishetty, et al.Pageof 113